v3.26.1
Earnings Per Share
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic net income per share is computed by dividing net income attributable to common stockholders by the weighted-average
number of common shares outstanding. Diluted net income per share is computed by dividing net income attributable to
common stockholders by the weighted-average number of common shares outstanding plus the dilutive effect of outstanding
securities, and such dilutive effect is computed using the treasury stock method.
The following table sets forth the computation of basic and diluted net income per share (in thousands, except share and per
share amounts):
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
Basic:
Net income attributable to common stockholders
$16,899
$72,950
$56,749
$114,333
Weighted-average number of common shares
141,688,279
140,374,892
141,478,312
140,219,452
Net income per common share
$0.12
$0.52
$0.40
$0.82
Diluted:
Net income attributable to common stockholders
$16,899
$72,950
$56,749
$114,333
Weighted-average number of common shares
143,052,519
141,517,661
142,414,946
141,111,732
Net income per common share
$0.12
$0.52
$0.40
$0.81
The following table sets forth the components of the denominator for the computation of basic and diluted net income per
share for net income attributable to Ardent Health, Inc. stockholders:
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
Weighted-average number of common shares - basic
141,688,279
140,374,892
141,478,312
140,219,452
Effect of dilutive securities(1)
1,364,240
1,142,769
936,634
892,280
Weighted-average number of common shares - diluted
143,052,519
141,517,661
142,414,946
141,111,732
(1)
The effect of dilutive securities does not reflect weighted-average potential common shares from restricted stock and restricted stock units of
994,234 and 850,744 for the three months ended June 30, 2026 and 2025, respectively, and 2,488,145 and 641,768 for the six months ended June
30, 2026 and 2025, respectively, because their effect was antidilutive as calculated under the treasury stock method.